V. Paul Doria‐Rose

4.8k total citations · 3 hit papers
80 papers, 3.5k citations indexed

About

V. Paul Doria‐Rose is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, V. Paul Doria‐Rose has authored 80 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 16 papers in Pathology and Forensic Medicine. Recurrent topics in V. Paul Doria‐Rose's work include Colorectal Cancer Screening and Detection (54 papers), Global Cancer Incidence and Screening (31 papers) and Gastric Cancer Management and Outcomes (30 papers). V. Paul Doria‐Rose is often cited by papers focused on Colorectal Cancer Screening and Detection (54 papers), Global Cancer Incidence and Screening (31 papers) and Gastric Cancer Management and Outcomes (30 papers). V. Paul Doria‐Rose collaborates with scholars based in United States, Canada and Netherlands. V. Paul Doria‐Rose's co-authors include Ann G. Zauber, Joan L. Warren, Pamela M. Marcus, Carolyn M. Rutter, Michael Barrett, Nancy N. Baxter, Thérèse A. Stukel, Chyke A. Doubeni, Iris Lansdorp‐Vogelaar and Noel S. Weiss and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

V. Paul Doria‐Rose

77 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies

2016 335 citations Amy B. Knudsen, Ann G. Zauber et al. profile →
Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study

2016 305 citations Chyke A. Doubeni, Douglas A. Corley et al. Gut profile →
Colorectal Cancer Screening

2021 186 citations Amy B. Knudsen, Carolyn M. Rutter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Paul Doria‐Rose United States	29	2.7k	1.7k	850	606	316	80	3.5k
Mette Kalager Norway	28	3.0k 1.1×	1.7k 1.0×	846 1.0×	726 1.2×	299 0.9×	101	4.0k
Paul C. Schroy United States	32	2.5k 1.0×	1.3k 0.8×	971 1.1×	713 1.2×	147 0.5×	91	3.5k
Magnus Løberg Norway	22	2.1k 0.8×	1.5k 0.9×	706 0.8×	603 1.0×	141 0.4×	74	2.8k
Carlo Senore Italy	39	3.9k 1.5×	2.8k 1.6×	1.1k 1.3×	1.4k 2.4×	443 1.4×	157	4.9k
Joanna Didkowska Poland	16	2.3k 0.9×	1.8k 1.1×	446 0.5×	694 1.1×	191 0.6×	77	2.9k
Laura C. Seeff United States	27	4.2k 1.6×	2.1k 1.2×	1.3k 1.5×	1.1k 1.8×	404 1.3×	53	5.1k
Andrew M. D. Wolf United States	14	2.9k 1.1×	1.4k 0.8×	694 0.8×	485 0.8×	804 2.5×	24	4.5k
Kate Wooldrage United Kingdom	20	2.0k 0.8×	1.4k 0.8×	774 0.9×	596 1.0×	188 0.6×	40	2.5k
D. Max Parkin United Kingdom	13	2.3k 0.9×	908 0.5×	594 0.7×	604 1.0×	904 2.9×	17	3.2k
Alain Demers Canada	24	1.5k 0.6×	924 0.5×	410 0.5×	512 0.8×	608 1.9×	70	2.5k

Countries citing papers authored by V. Paul Doria‐Rose

Since Specialization

Citations

This map shows the geographic impact of V. Paul Doria‐Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Paul Doria‐Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Paul Doria‐Rose more than expected).

Fields of papers citing papers by V. Paul Doria‐Rose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Paul Doria‐Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Paul Doria‐Rose. The network helps show where V. Paul Doria‐Rose may publish in the future.

Co-authorship network of co-authors of V. Paul Doria‐Rose

This figure shows the co-authorship network connecting the top 25 collaborators of V. Paul Doria‐Rose. A scholar is included among the top collaborators of V. Paul Doria‐Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Paul Doria‐Rose. V. Paul Doria‐Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Benmei, Michael T. Halpern, V. Paul Doria‐Rose, et al.. (2025). Lung Cancer Screening Rates in the United States: Contribution of the 2020 NHIS Estimates to National and State-Level Trends. American Journal of Preventive Medicine. 69(1). 107626–107626. 1 indexed citations

Doria‐Rose, V. Paul, Gerard A. Silvestri, Danielle D. Durham, et al.. (2025). The United States’ Early Experience With Lung Cancer Screening—Creation of a National Data Linkage: A Brief Report. JTO Clinical and Research Reports. 6(6). 100825–100825.

Halpern, Michael T., Benmei Liu, Douglas R. Lowy, et al.. (2024). The Annual Cost of Cancer Screening in the United States. Annals of Internal Medicine. 177(9). 1170–1178. 12 indexed citations

Rendle, Katharine A., Anil Vachani, Andrea N. Burnett‐Hartman, et al.. (2024). Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice. Annals of Internal Medicine. 177(1). 18–28. 22 indexed citations

Ziebell, Rebecca A., Aruna Kamineni, Amanda I. Phipps, et al.. (2023). Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1382–1390. 1 indexed citations

Silvestri, Gerard A., Lenka Goldman, Nichole T. Tanner, et al.. (2023). Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging. CHEST Journal. 164(1). 241–251. 58 indexed citations

Selby, Kevin, Emma Levine, Aruna Kamineni, et al.. (2023). Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review. JNCI Journal of the National Cancer Institute. 115(4). 375–384. 7 indexed citations

Doria‐Rose, V. Paul, Nancy Breen, Martin L. Brown, et al.. (2022). A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute. JNCI Monographs. 2022(59). 21–27. 2 indexed citations

Ko, Cynthia W., V. Paul Doria‐Rose, Michael Barrett, et al.. (2019). Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: A case-control study. PLoS ONE. 14(12). e0226027–e0226027. 10 indexed citations

10.

Kamineni, Aruna, Jasmin A. Tiro, Elisabeth F. Beaber, et al.. (2018). Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. International Journal of Cancer. 144(6). 1460–1473. 22 indexed citations

11.

Doubeni, Chyke A., Douglas A. Corley, Virginia P. Quinn, et al.. (2016). Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 67(2). 291–298. 305 indexed citations breakdown →

12.

Rutter, Carolyn M., Amy B. Knudsen, Tracey L. Marsh, et al.. (2016). Validation of Models Used to Inform Colorectal Cancer Screening Guidelines. Medical Decision Making. 36(5). 604–614. 48 indexed citations

13.

Benard, Vicki B., Cheryll C. Thomas, Jessica King, et al.. (2014). Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012.. PubMed. 63(44). 1004–9. 134 indexed citations

14.

Chubak, Jessica, Carolyn M. Rutter, Aruna Kamineni, et al.. (2013). Measurement in Comparative Effectiveness Research. American Journal of Preventive Medicine. 44(5). 513–519. 2 indexed citations

15.

Laiyemo, Adeyinka O., Chyke A. Doubeni, Paul F. Pinsky, et al.. (2013). Factors Associated with the Risk of Adenoma Recurrence in Distal and Proximal Colon. Digestion. 87(3). 141–146. 9 indexed citations

16.

Weissfeld, Joel L., Robert E. Schoen, Paul F. Pinsky, et al.. (2012). Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added Yield from a Second Screening Examination. JNCI Journal of the National Cancer Institute. 104(4). 280–289. 27 indexed citations

17.

Pinsky, Paul F., Robert E. Schoen, Joel L. Weissfeld, et al.. (2008). The Yield of Surveillance Colonoscopy by Adenoma History and Time to Examination. Clinical Gastroenterology and Hepatology. 7(1). 86–92. 87 indexed citations

18.

Newcomb, Polly A., Yingye Zheng, Victoria M. Chia, et al.. (2007). Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women. Cancer Research. 67(15). 7534–7539. 113 indexed citations

19.

Doria‐Rose, V. Paul. (2003). Doria-Rose and Edwards Respond to "Parity and Down's Syndrome". American Journal of Epidemiology. 158(6). 512–513.

20.

Doria‐Rose, V. Paul & Janet M. Scarlett. (2000). Mortality rates and causes of death among emaciated cats. Journal of the American Veterinary Medical Association. 216(3). 347–351. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact